HERA TRIAL: 2 Years versus 1 Year of Trastuzumab after Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up

Article Information

Published By 
Print ISSN 
Online ISSN 

Author Information

  1. Emma Hitt Nichols, PhD
  1. Martine J. Piccart-Gebhart, MD, PhD
    1. Université Libre de Bruxelle and Jules Bordet Institute, Brussels, Belgium
View Full Text

Article usage

AbstractFullPDF
Apr 2015700
May 2015100
Jun 2015300
Jul 2015511
Aug 2015200
Sep 2015300
Oct 2015134
Nov 2015100
Total2345

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.